Peripheral neuropathy — all decisions

The Veteran is granted special monthly compensation based on the need for regular aid and attendance due to his service-connected disabilities.

The Board granted service connection for right upper, left upper, right lower, and left lower extremity peripheral neuropathy due to in-service herbicide agent exposure.

The Board denied the claims for increased rating for diabetes and hearing loss, granted service connection for chronic kidney disease secondary to diabetes, and remanded the claim for service connection for peripheral neuropathy of the upper extremity.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The Board denied service connection for dizziness, right lower extremity neuropathy, left lower extremity neuropathy, left upper extremity neuropathy, right upper extremity neuropathy, shortness of breath, and skin cancer as there was no persuasive evidence of a current disability.

The Board granted service connection for bipolar I disorder and remanded the claims for nephrogenic diabetes insipidus, diabetes mellitus type II, chronic kidney disease, and peripheral neuropathy as secondary to the service-connected bipolar I disorder.

The Board granted restoration of the 80 percent disability rating for bilateral lower extremity peripheral neuropathy of the sciatic nerve, effective July 14, 2023. The Board also granted increased ratings for some upper and lower extremity conditions but denied others.

The Board granted service connection for left and right lower extremity peripheral neuropathy based on the Veteran's exposure to toxic herbicides during his service in Vietnam.

The Board granted service connection for hypertension prior to August 10, 2022, and dismissed several other claims related to various disabilities.

The appeal for service connection for left and right hand peripheral neuropathy was withdrawn by the Veteran, resulting in the dismissal of the appeal.

The Board granted service connection for Type II diabetes mellitus, diabetic neuropathy of various nerves, and hypertension under the PACT Act. The claims for secondary conditions were remanded.

The Board granted service connection for right and left arm and right and left leg sensorimotor axonal neuropathy, finding that the Veteran's conditions are related to his presumed exposure to herbicide agents during his active duty service in Vietnam.

The Board granted service connection for left and right lower extremity peripheral neuropathy, as secondary to the Veteran's service-connected diabetes. The Board also granted an initial 20 percent rating for thoracolumbar strain effective from February 8, 2010.

The appeal for service connection for diabetic peripheral neuropathy (claimed as right foot condition to include right leg) was dismissed due to a procedural error in the Veteran's election of review options.

The Veteran's Parkinson's disease and diabetes mellitus are service-connected due to in-service herbicide exposure, with an effective date from February 23, 2018.

The Board denied service connection for GERD and various increased rating claims while granting a 30% disability evaluation for IBS with constipation, an effective date of November 12, 2021, for the award of a 20% rating for right shoulder instability, and a 10% rating for painful motion of the right knee.

The Board granted an earlier effective date for the award of service connection for right lower extremity polyneuropathy to August 5, 1994, and remanded issues related to increased rating and service connection for a right eye disability.

The Board remands the claims for increased ratings of various peripheral neuropathies and diabetes mellitus to obtain updated medical records.

The Veteran's claim for an earlier effective date of July 15, 2008, but no earlier, for the award of special monthly compensation (SMC) for aid and attendance is granted.

The Board granted service connection for diabetes mellitus type II and an initial 10 percent rating, but no higher, for hypertension. The remaining claims for service connection were denied.